ADI
57
-4
O
40
-4
MAT
50
4
K
65
2
DE
50
8
TRIP
54
2
TDC
59
4
CSCO
48
4
AES
49
2
MO
39
-3
MPC
49
2
MAC
61
3
CI
75
3
MNST
52
-5
TXT
59
3
OXY
40
2
RIG
25
2
BXP
67
5
DLTR
26
-9
CMCSA
52
4
ADI
57
-4
O
40
-4
MAT
50
4
K
65
2
DE
50
8
TRIP
54
2
TDC
59
4
CSCO
48
4
AES
49
2
MO
39
-3
MPC
49
2
MAC
61
3
CI
75
3
MNST
52
-5
TXT
59
3
OXY
40
2
RIG
25
2
BXP
67
5
DLTR
26
-9
CMCSA
52
4
Financhill
Back

Insmed Vs. Cytokinetics Industry Stock Comparison

Buy
61

INSM
Insmed

Last Price:
73.91
Seasonality Move:
0.64%
Buy
52

CYTK
Cytokinetics

Last Price:
54.04
Seasonality Move:
-7.4%
Buy
61
Insmed (INSM) is a Buy

Is Insmed a Buy, Sell or Hold?

  • The current Insmed [INSM] share price is $73.91. The Score for INSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $54.03. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

INSM Stock Price Chart

What is Insmed's stock price today?

  • The Insmed share price today is $73.91
    The current trend is relatively stagnant and INSM is experiencing slight buying pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $54.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 49.97 Sell
Chaikin Money Flow: 127063 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.77 - 77.17) Sell
Bollinger Bands (100): (38.41 - 79.27) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 43.98 Sell
Chaikin Money Flow: -356654 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.67 - 56.93) Sell
Bollinger Bands (100): (52.17 - 60.95) Sell

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.82 Buy
20-day SMA: 75.16 Sell
50-day SMA: 74.27 Sell
200-day SMA: 43.34 Buy
8-day EMA: 73.28 Buy
20-day EMA: 74.08 Sell
50-day EMA: 71.03 Buy
200-day EMA: 49.68 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.66 Sell
20-day SMA: 55.86 Sell
50-day SMA: 56.16 Sell
200-day SMA: 62.22 Sell
8-day EMA: 54.73 Sell
20-day EMA: 55.41 Sell
50-day EMA: 56.01 Sell
200-day EMA: 56.47 Sell

Insmed Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.10 per share, and an increase next year of $1.11 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.28 per share, and an increase next year of $0.29 per share.

Insmed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):